Cargando…
The Global HIV/AIDS Vaccine Enterprise: Scientific Strategic Plan
The development of an HIV vaccine remains one of the most difficult challenges confronting biomedical research today. A new international collaboration shares its plan to address the challenge
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544553/ https://www.ncbi.nlm.nih.gov/pubmed/15740411 http://dx.doi.org/10.1371/journal.pmed.0020025 |
Ejemplares similares
-
Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions: A summary report from a Global HIV Vaccine Enterprise Working Group
por: Montefiori, David, et al.
Publicado: (2007) -
Improving Defences at the Portal of HIV Entry: Mucosal and Innate Immunity: A summary report from a Global HIV Vaccine Enterprise Working Group
por: Shattock, Robin J, et al.
Publicado: (2008) -
The National Security Implications of HIV/AIDS
por: Feldbaum, Harley, et al.
Publicado: (2006) -
Rationing Antiretroviral Therapy for HIV/AIDS in Africa: Choices and Consequences
por: Rosen, Sydney, et al.
Publicado: (2005) -
Addressing disparities in the health of persons with HIV attributable to unstable housing in the United States: The role of the Ryan White HIV/AIDS Program
por: Griffin, Amy, et al.
Publicado: (2020)